LANSING, Mich. (WLNS) — Canceling federal mRNA vaccine projects threatens much more than pandemic response, according to Michigan State University’s Director of the Precision Health Program Anna Moore ...
Moderna shares are down on Monday, pulling back following a recent report highlighting its latest cancer trial results.
The University of Auckland is hosting the research as part of the Global COVID Vaccine Safety (GCoVS) Project. Scientists ...
Moderna, Inc. stock is up ~60% YTD on cancer vaccine trial data, 2026 readouts, and 2025 financials. Click for this updated look at MRNA stock prospects.
Zacks Investment Research on MSN
MRNA & MRK's Personalized Cancer Therapy Delivers Strong 5-Year Data
Shares of Moderna MRNA were up 15.8% on Jan. 21, after the company and its partner Merck MRK announced positive median ...
LANSING, Mich. (WLNS) — Canceling federal mRNA vaccine projects threatens much more than pandemic response, an expert at Michigan State University warned. Last week, Secretary of Health and Human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results